Merck & Company, Inc. (MRK) Given "Hold" Rating at Berenberg Bank

James Marshall
November 19, 2017

Perennial Advisors LLC now owns 1,626 shares of the company's stock valued at $104,000 after acquiring an additional 157 shares during the last quarter. The institutional investor held 6.24 million shares of the health care company at the end of 2017Q2, valued at $400.06M, down from 7.43 million at the end of the previous reported quarter.

In related news, Director Thomas H. Glocer sold 5,000 shares of the stock in a transaction that occurred on Wednesday, November 8th. About 1.41M shares traded. (NYSE:MRK) has risen 16.86% since November 18, 2016 and is uptrending. It has outperformed by 0.16% the S&P500. Citizens Northern reported 3,607 shares stake. Jefferies Group LLC cut shares of Merck & from a "hold" rating to an "underperform" rating in a research report on Wednesday, November 1st. Tuesday Morning Corporation now has $123.77M valuation. The stock decreased 0.63% or $0.87 on November 17, reaching $138. About 234,652 shares traded. Exponent, Inc. (EXPO) has risen 21.10% since November 17, 2016 and is uptrending. It has underperformed by 14.17% the S&P500.

Sectoral Asset Management Inc decreased Portola Pharmaceuticals (NASDAQ:PTLA) stake by 181,898 shares to 422,143 valued at $23.71 million in 2017Q2. It also reduced Verastem Inc. Common (NASDAQ:AMZN) stake by 2,523 shares and now owns 9,998 shares. Celgene Corp (NASDAQ:CELG) was reduced too. Therefore 57% are positive. (NYSE:MRK) has "Outperform" rating given on Friday, September 8 by Credit Suisse. The stock has "Buy" rating by Piper Jaffray on Thursday, October 26. The rating was downgraded by Bank of America on Wednesday, January 27 to "Neutral". The rating was maintained by Oppenheimer with "Hold" on Tuesday, August 22. Merck KGaA has a consensus rating of "Buy" and an average price target of €109.00 ($126.74). The firm earned "Buy" rating on Monday, May 2 by Stifel Nicolaus. The firm earned "Hold" rating on Friday, April 15 by Jefferies.

Since May 25, 2017, it had 0 insider buys, and 4 selling transactions for $89,700 activity. Shares for $172,900 were bought by Becker Steven R on Thursday, June 1. Its down 0.98% from 14.27M shares previously. 1 analysts say it's a Hold while 0 analysts provided their expert opinion as Sell. Shares for $27,600 were sold by Pedersen Esben W. The New York-based Prelude Cap Mngmt Limited Liability Company has invested 0.03% in Tuesday Morning Corporation (NASDAQ:TUES). Stadion Money Limited Liability Com holds 29,278 shares or 0.06% of its portfolio. Sandy Spring Natl Bank reported 1.5% of its portfolio in Johnson & Johnson (NYSE:JNJ). Concourse Management Limited Liability accumulated 20,942 shares. It improved, as 18 investors sold PEGI shares while 41 reduced holdings. Sentry Invests Corp accumulated 86,300 shares. Primecap Mgmt Ca reported 2.22 million shares. Bridges Mngmt holds 0.4% or 46,436 shares in its portfolio. Goldman Sachs Group, Inc. Pattern Energy had 33 analyst reports since July 24, 2015 according to SRatingsIntel. Eleven investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. Therefore 65% are positive. UBS AG upped their target price on Merck & from $70.00 to $72.00 and gave the company a "buy" rating in a research report on Monday, July 31st. On Tuesday, November 17 the stock rating was maintained by Argus Research with "Buy". Morgan Stanley downgraded the shares of MRK in report on Monday, October 30 to "Equal-Weight" rating. Rk Capital Management Llc owns 127,084 shares or 1.49% of their U.S. portfolio.

Equity analyst Leerink Swann lowered the price target of the stock on October 30 changing the forecast from $70.00 to $69.00 and stated a "Market Perform" rating. Ci Invests Inc holds 2.87M shares. Merck KGaA now has an average rating of Buy and a consensus target price of €109.00 ($126.74). Factory Mutual Ins Company invested 0.61% in Merck & Co., Inc. They expect $0.94 EPS, up 5.62% or $0.05 from last year's $0.89 per share. MRK's profit will be $2.56 billion for 14.73 P/E if the $0.94 EPS becomes a reality.

Apg Asset Management Nv decreased its stake in Merck & Co Inc (MRK) by 15.96% based on its latest 2017Q2 regulatory filing with the SEC.

Vigilant Capital Management LLC increased its position in Merck & by 16.7% during the 1st quarter. Its up 0.08, from 0.99 in 2017Q1.

A number of other large investors have also modified their holdings of MRK. 111 funds opened positions while 603 raised stakes. Buffington Mohr Mcneal has 0.11% invested in Merck & Co., Inc. (NYSE:MRK). Brick And Kyle Associate invested in 48,181 shares or 2.65% of the stock. Finally, Solaris Asset Management LLC increased its position in Merck & by 6.3% during the 2nd quarter. (NYSE:MRK) for 19,967 shares. 1 analysts gave its stock an Outperform rating. Coho accumulated 1.63 million shares or 2.61% of the stock. 530.91 million shares or 0.81% less from 535.24 million shares in 2017Q1 were reported. Andra Ap has invested 0.38% of its portfolio in International Business Machines Corp. Baker Avenue Asset Limited Partnership holds 0.17% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Gfs Advsr Lc owns 54,890 shares. World stated it has 95.14M shares or 1.43% of all its holdings. Michigan-based Lafleur Godfrey Ltd Liability Com has invested 4.1% in Merck & Co., Inc. (NYSE:MRK). Caxton Assocs LP reported 9,000 shares or 0% of all its holdings. Employees Retirement Association Of Colorado reported 1.09% of its portfolio in Merck & Co., Inc.

Other reports by Click Lancashire

Discuss This Article